A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance

Hao Zheng, Shilin Li, Liang Ma, Ling Cheng, Chongyang Deng, Zhizhi Chen, Caifeng Xie, Mingli Xiang, Wei Jiang, Lijuan Chen
  • European Journal of Pharmacology, June 2011, Elsevier
  • DOI: 10.1016/j.ejphar.2011.03.033

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Liang Ma